Data Factory
Reading the graph
Reading the graph
Private Equity
New York, NY
Altaris, LLC is a healthcare investment firm. We seek to build market-leading companies that deliver innovation and efficiency.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures, news and newswire. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| Altaris Health Partners Vi-A, L.P. | 2024 | Unknown | Private Equity Fund | n/a | $814M | 0 |
| A4048, L.P. | 2024 | Unknown | Private Equity Fund | n/a | $50.5M | 0 |
| Altaris VI T-Co-Invest, L.P | 2024 | Unknown | Private Equity Fund | n/a | $40.5M | 0 |
| Altaris Vi-4042, L.P. | 2024 | Unknown | Private Equity Fund | n/a | $40.5M | 0 |
| Altaris Health Partners VI, L.P. | 2024 | Unknown | Private Equity Fund | n/a | $2.7B | 4 |
| A5083, L.P. | 2024 | Unknown | Private Equity Fund | n/a | $80.5M | 0 |
| Altaris V-4042, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $64.4M | 0 |
| Altaris Padagis Co-Invest, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $43.1M | 0 |
| Altaris Padagis Co-Invest-A, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $14.7M | 0 |
| Altaris V-4041, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $27.7M | 0 |
| Altaris V-5082, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $43.9M | 0 |
| Altaris Health Partners V-A, L.P. | 2021 | Active deployment | Private Equity Fund | n/a | $897M | 0 |
| Altaris Health Partners V, L.P. | 2021 | Active deployment | Private Equity Fund | n/a | $1.9B | 1 |
| Altaris Constellation Partners IV, L.P. | 2018 | Unknown | Private Equity Fund | n/a | $376M | 0 |
| Altaris Health Partners IV, L.P. | 2018 | Unknown | Private Equity Fund | n/a | $1.2B | 0 |
| Altaris Constellation Partners, L.P. | 2017 | Mature | Private Equity Fund | n/a | $261M | 0 |
| Altaris Health Partners III, L.P. | 2014 | Mature | Private Equity Fund | n/a | $760M | 0 |
| Altaris Health Partners, L.P. | n/a | Wound down | Private Equity Fund | n/a | $23.3M | 0 |
| Altaris Health Partners II, L.P. | n/a | Harvest | Private Equity Fund | n/a | $30.7M | 0 |
| AHP Co-Investment, L.P. | n/a | Wound down | Private Equity Fund | n/a | $768,755 | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Tegria Services Group, Inc. | n/a | platform | control | Jan 6, 2026 | n/a | active |
| Analogic | n/a | unknown | unknown | n/a | n/a | unknown |
| Chemical Computing Group | n/a | unknown | unknown | n/a | n/a | unknown |
| Forj Medical | n/a | unknown | unknown | n/a | n/a | unknown |
| Kindeva Drug Delivery | n/a | unknown | unknown | n/a | n/a | unknown |
| Minarias Regenerative Medicine | n/a | unknown | unknown | n/a | n/a | unknown |
| Padagis | n/a | unknown | unknown | n/a | n/a | unknown |
| Sharecare | n/a | unknown | unknown | n/a | n/a | unknown |
| Solesis | n/a | unknown | unknown | n/a | n/a | unknown |
| Tegria | n/a | unknown | unknown | n/a | n/a | unknown |
| Trean Insurance Group | n/a | unknown | unknown | n/a | n/a | unknown |
| Veranova | n/a | unknown | unknown | n/a | n/a | unknown |
| Clearwater Security and Compliance | n/a | unknown | unknown | n/a | Oct 8, 2025 | exited |
| Limited partner | Fund | Commitment | Committed | Vintage |
|---|---|---|---|---|
| New York State Common Retirement Fund | Altaris Health Partners VI, L.P. | $175M | n/a | 2023 |
| New Jersey Division of Investment | Altaris Health Partners V, L.P. | $100M | n/a | 2020 |
| New Jersey Division of Investment | Altaris Health Partners VI, L.P. | $150M | n/a | 2023 |
| Los Angeles City Employees' Retirement System | Altaris Health Partners VI, L.P. | $40.0M | n/a | 2023 |
Also named here, with no published line of their own (reach them through the firm): George Edward Aitken-Davies (Member), Daniel Gabor Tully (Member), Charles Terrence Mullens (Chief Compliance Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan